【レポートの概要（一部）】
1. Report Overview
1.1 Global Gene Therapy Market Overview
1.2 Benefits of This Report
1.3 How This Report Delivers
1.4 Key Questions Answered by This Analytical Report
1.5 Who is This Report For?
1.6 Methods of the Study
1.7 Frequently Asked Questions (FAQ)
1.8 Associated Visiongain Reports
1.9 About Visiongain
2. Introduction to Gene Therapy
2.1 What is Gene Therapy?
2.2 Types of Gene Therapy
2.3 Products Excluded from the Report
2.4 Gene Therapy Vectors
3. Gene Therapy World Market: Leading Treatments and Forecasts, 2014-2026
3.1 The World Market for Gene Therapy: Overview of Products
3.2 Gendicine (rAd-p53) – The First Gene Therapy to Market
3.3 Oncorine: Growth is Hindered by Certain Factors
3.4 Glybera: Pricing Will Determine the Future of this Promising Gene Therapy
3.4.1 Glybera Pricing Strategy
3.4.2 Glybera Revenue Forecast, 2014-2026
3.5 Neovasculgen: Russia’s First Gene Therapy
3.5.1 Neovasculgen: Historical Performance and Revenue Forecast 2014-2026
4. Gene Therapy World Market and Disease Submarkets, 2014-2026
4.1 The Global Market for Gene Therapy Drug Treatments in 2014
4.2 Gene Therapy Market Forecast, 2014-2026
4.3 Gene Therapy for Cancer
4.3.1 Clinical Trials for Cancer
4.3.2 The Cancer Gene Therapy Treatment Submarket Forecast 2014-2026
4.4 Gene Therapy for Rare Diseases
4.4.1 The Rare Disease Treatment Submarket Forecast 2014-2026
4.5 Gene Therapy for Cardiovascular Diseases
4.5.1 The Cardiovascular Disease Treatment Submarket Forecast 2014-2026
4.6 Gene Therapy for Ophthalmologic Diseases
4.6.1 Advanced Stage Gene Therapies for Ophthalmologic Diseases
4.6.2 The Ophthalmologic Disease Treatment Submarket Forecast 2014-2026
4.7 Gene Therapy for Other Diseases
4.7.1 The Other Disease Treatment Submarket Forecast 2014-2026
4.8 Changing Market Shares: Cancer Disease Gene Therapies Will Eventually Become Market Leader
5. Companies of Interest in the Gene Therapy Market: Robust Pipelines Will Yield Revenue in the Future
5.1 UniQure- the First Commercial Stage Gene Therapy Company in the West
5.2 Biogen – Focusing on Ophthalmologic and Rare Disease Gene Therapies
5.3 Bluebird Bio: Gene Editing Technology
5.4 Spark Therapeutics- Strong Change to Become the First Company with Marketed Gene Therapy in the US
5.5 Applied Genetic Technologies Corporation: Specialisation in Ophthalmologic Diseases
5.6 Oxford Biomedica: Collaboration as a Strategy
5.7 GenSight Biologics – Novel Mitochondrial Technology Platform
5.8 Gene Therapy and Big Pharma: Collaborations
6. R&D Pipeline Analysis and Forecasts, 2014-2026
6.1 Pipeline
6.2 Pipeline Analysis
6.3 GSK2696273 – GSK
6.4 Collategene (AMG0001) – AnGes MG/Vical
6.5 BC-819 – BioCancell
6.6 BC-821 – BioCancell
6.7 Lenti-D – Bluebird Bio
6.8 LentiGlobin (LentiGlobin BB305) – Bluebird Bio
6.9 SPK-RPE65 – Spark Therapeutics
6.10 SPK-CHM – Spark Therapeutics
6.11 SPK-FIX – Spark Therapeutics/Pfizer
6.12 SPK-TPP1- Spark Therapeutics
6.13 Invossa (TissueGene-C) – TissueGene Inc/Kolon Life Science
6.14 VM202-DPN – ViroMed
6.15 Important Pipeline Technology Developments
6.16 The Future of the Gene Therapy Pipeline
7. Qualitative Analysis of the Gene Therapy Market, 2016-2026
7.1 SWOT Analysis of the Gene Therapy Treatment Market, 2016
7.2 Strengths: A Vast Pipeline for a Wide Range of Indications
7.3 Weaknesses: Low Patient Populations Cannot Sustain Long-Term Growth
7.4 Opportunities and Threats for the Gene Therapy Drug Market, 2016-2026
7.5 Opportunities: Collaborations and Novel Technologies Will Pave the Way
7.6 Threats: Expensive Drugs with Strict Regulations
7.7 National Markets: Regulation of the Gene Therapy Market
7.7.1 Gene Therapy Regulations: Evolving with the Market
7.7.2 US Regulations: Strict Regulation of a Cautious Market
7.7.3 EU Regulations: One Approval So Far
7.7.4 Japanese Regulations: A Rigorous Process
8. Research Interviews from Our Survey
8.1 Interview with Karen Aiach, Founder and CEO of Lysogene, Neuilly-sur-Seine, France
8.1.1 The Origin of Lysogene and its Focus
8.1.2 Strategy and Challenges for Gene Therapy Development
8.1.3 Regulations and Their Effect on the Future of Gene Therapy Development in the EU
8.2 Interview with Dr Fungayi Chidothe, MD, Senior Business Development Manager, Cell Therapy Catapult, London, UK
8.2.1 Cell Therapy Catapult: Supporting the Translation of Research into Marketable Therapies
8.2.2 Trends in the Gene Therapy Industry
8.2.3 The Challenges of Bringing a Gene Therapy to Market
8.2.4 Regulatory and Reimbursement Concerns for Gene Therapies
8.2.5 The Potential and Promise in Gene Therapy Applications
8.3 Interview with Dr Artur Isaev, CEO of HSCI – Human Stem Cells Institute, Moscow, Russia
8.3.1 The Human Stem Cells Institute: Innovation in Russia
8.3.2 Strategies for Marketing Neovasculgen®
8.3.3 The Benefits of the Developed Versus Emerging Marketplace
8.3.4 Challenges of Producing Gene Therapies and a Future Outlook
9. Conclusions from Our Research and Analysis
9.1 The World Gene Therapy Treatment Market: Current World Outlook
9.1.1 Leading Gene Therapy Treatment Submarkets and Products, 2015-2026
9.1.2 Driver for Growth to 2026: A Vast Pipeline of Gene Therapy Products
9.1.3 Leading Regional Markets and Companies: Partnerships Will Achieve Success
9.2 The Future of the Gene Therapy Treatment Market
【レポート販売概要】
■ タイトル：遺伝子治療の世界市場：研究開発および売上予測2016-2026■ 英文：Gene Therapy R&D and Revenue Forecasts 2016-2026 : Prospects for Drugs Treating Cancer, Cardiovascular Disorders, Eye Conditions, Rare Diseases and Other Needs
■ 発行日：2016年1月
■ 調査会社：visiongain
■ 商品コード：VGAIN6022516
■ 調査対象地域：グローバル
- カーボンナノチューブの世界市場：MWCNT、SWCNTAbout Carbon Nanotubes Carbon nanotubes are cylinder-shaped graphite sheets. They may consist of a single layer (SWCNTs) or many layers (MWCNTs). They have high thermal and electrical conductivity and are utilized in a wide variety of applications. Some high growth applications of carbon nanotubes are in electronic devices, electrochemical sensors and biosensors, transistors, lithium-ion (li-ion) …
- 手術器具追跡システムの世界市場分析：製品別（ハードウェア、ソフトウェア、サービス）、技術別（バーコード、RFID）、エンドユーザー別、地域別（北アメリカ、ヨーロッパ、アジア太平洋、ラテンアメリカ、MEA）、セグメント予測、2014-2025The global surgical instrument tracking systems market is expected to reach a value of USD 442.9 million by 2025, according to a new report by Grand View Research, Inc. Increasing incidence of surgical instruments being left behind after surgery is the most significant factor anticipated to boost the market growth during the forecast period. Annually in the U.S, around 4,500 to 6,000 surgical inst …
- 世界の感染予防・感染管理市場（2014-2018）About Infection Prevention and Control Infection prevention and control is the most important and significant step in the development and maintenance of products in the Medical Devices, Pharmaceuticals, and Food industries. Sterilization and disinfection protect different products and materials from decaying or being spoiled by microbes. Sterilization and disinfection can be performed by using var …
- Trypanosomiasis：グローバル臨床試験レビューH1, 2013Trypanosomiasis Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Trypanosomiasis Global Clinical Trials Review, H1, 2013" provides data on the Trypanosomiasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Trypanosomiasis. It includes an overview of the trial numbers and their recruitment status as …
- グローバルIPTV市場動向Product Synopsis We estimate that the 100-millionth IPTV customer globally came online in November 2013. China, France and the US together account for over half of all subscriptions, but penetration levels vary greatly. We expect global IPTV revenue to rise at a 11.8% CAGR from 2013 to 2018. A blend of primary research, market indicators and qualitative analysis, our IPTV Research in Focus helps i …
- マスターバッチ（樹脂用着色剤）の世界市場：White/Black/Colorマスターバッチ、添加剤マスターバッチ、フィラーマスターバッチMasterbatch is a solid or liquid mixture of additive or pigments used for coloring or enhancing other properties of polymers, such as UV stabilizing, flame retardation, antistatic and antilocking. Major end-user industries for masterbatch include packaging, building & construction, automotive, consumer goods, textiles, agriculture, and furniture. Steady economic growth, rapid pace of industrializa …
- 世界のデーターセンター建設市場動向（2012-2016）TechNavio's analysts forecast the Global Data Center Construction market to grow at a CAGR of 15.78 percent over the period 2012-2016. One of the key factors contributing to this market growth is the growing demand for colocation services. The Global Data Center Construction market has also been witnessing the use of alternative energy sources. However, the unstable economic conditions could pose …
- Becton, Dickinson and Company：市場シェア分析Becton, Dickinson and Company Market Share Analysis Summary GlobalData’s new report, “Becton, Dickinson and Company Market Share Analysis” provides in-depth information on Becton, Dickinson and Company s market position in the different medical equipment markets it operates in. The report provides Becton, Dickinson and Company market share information in eight key market categories – Histology And …
- トップ10バイオプロセス技術の世界市場予測（～2021）：細胞培養、細胞増殖、細胞数、細胞株開発、フローサイトメトリー、シングルユースバイオプロセス、バイオロジクス安全性試験、タンジェント流ろ過、ウイルスろ過、地域別 分析The global top 10 bioprocess technology market is expected to reach USD 71.03 billion by 2021 from USD 39.30 billion in 2016, at a CAGR of 12.4% from 2016 to 2021. On the basis of type, the market is segmented into cell culture, cell expansion, cell counting, flow cytometry, single-use bioprocessing, cell line development, virus filtration, biologics safety testing, pyrogen testing, and tangential …
- 歩数計の世界市場2015-2019About Pedometers A pedometer, also known as step counter, is a portable electronic/electromechanical device that counts the number of steps taken by a user while running/jogging/walking. The number of steps is counted by detecting the motion of the user's hip. Pedometers are commonly used by sportsperson. However, they are now popular among morning joggers/walkers, who consider this as a motivator …
- イギリスの自動微生物検査市場2014Complete report $6,950. DataPack (test volumes, sales forecasts, supplier shares) $4,500. “UK Automated Microbiology Market 2014” is a new analysis of major business opportunities emerging in the U.K. automated microbiology market during the next five years. The report examines key trends, reviews current and emerging assays; analyzes potential applications of innovati …
- 自閉症（Autism）：グローバル臨床試験レビュー（2014年上半期）Autism Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Autism Global Clinical Trials Review, H1, 2014" provides data on the Autism clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Autism. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction ac …
- 臭素の世界市場動向2014/2015The report presents a thorough study of bromine, covering both global and regional markets. It aims to give a proper picture of the market, its trends, perspectives and opportunities. Comprehensive data showing bromine worldwide production, consumption, trade statistics and prices are provided. Each country’s market overview covers the following: bromine production in the country, major manufactur …
- 紫外線硬化樹脂および配合製品の世界市場予測（～2021）The global UV curable resins market is projected to reach USD 3.05 Billion by 2021, at a CAGR of 8.12% from 2016 to 2021. The key drivers of the market are environmental concerns, growing awareness, stringent regulations for VOC emissions, and high performance of UV curable resins owing to its superior mechanical properties. UV curable formulated products include coatings, inks, and adhesives. The …
- 世界の医薬品卸売及び流通市場：地域別分析、主要企業分析Trends and revenue potentials for distributing and wholesaling of medicines Where’s the drug wholesaler and distribution (W&D) market heading? Discover revenue predictions there to 2024. Also find trends in business and technology, assessing prospects and opportunities to help your work and benefit your influence. In visiongain’s new report you gain sales forecasts there at overall world market, s …
